Although circulating leptin and insulin concentration is linked to intrauterine growth, fetal development and birth weight in full-term infants, there has been no enquiry into the influence of cord blood insulin and leptin for catch-up growth in preterm infants. The study evaluated the association of cord blood leptin with growth and weight gain of 96 premature babies during 6 months (corrected age). The temporal changes of anthropometric indexes over this period were calculated by repeated random regression (PROC MIXED) using SAS. Cord blood leptin was negatively associated with the rate of change in BMI (p ¼ 0.01) and length (p<0.001), from birth until 64 postnatal weeks. Insulin was positively associated with the change rate in BMI (p ¼ 0.03); however, this disappeared when adjusted for birth weight. For the first time, the association between lower leptin levels with greater catch up growth is shown for both BMI and length among preterm children. In conclusion, leptin levels at birth, but not insulin levels, predict growth rates.
INTRODUCTION
No period in an individual's life is as critical in determining future health and propensity to disease as the perinatal period. Undernutrition during fetal or early postnatal life may produce permanent changes in lipid metabolism and in the haemostatic factors that increase the risk for cardiovascular disease. Low birth weight has been linked to abnormalities in body composition in particular to an increase in central fat distribution in children and adults. Several hypothesis have been proposed to explain these links with low birth weight. [1] [2] [3] Intrauterine growth 4 and fetal development 5 are also related to circulating leptin concentrations. Leptin is a 16-kDa peptide hormone secreted from white adipocytes and implicated in the regulation of food intake and energy balance. Leptin provides the key afferent signal from fat cells in the feedback system that controls body fat stores. Among full-term infants, postnatal growth has been related to variation in leptin 6 and insulin secretion, which are major anabolic hormones. Cord leptin levels, but not insulin levels, were inversely related to changes in weight and length between birth and 4 months in term infants, 7 with levels of insulin being closely related to leptin levels. 6, 7 Positive associations between birth weight and leptin level have been reported for full-term infants 8 and preterm infants. 9 Adiposity at birth has also been positively associated with insulin. 7 In full-term infants, leptin plays an important role in the regulation of weight gain in early infancy; 7, 10 but there is no relationship between cord insulin levels and postnatal weight gain. 7 To our knowledge, there has been no study concerning cord blood levels of insulin and leptin in the catch-up growth of preterm infants. Attempts to understand the factors related to growth and weight gain in preterm infants may help explain the role of early undernutrition in obesity later in life. 11 In full-term children greater weight-for-height at the outset later affects adiposity, suggesting that newborn satiety may be predetermined by the uterine nutritional environment leading to greater volume variations in milk intake among infants. 12 Evaluating the rates of growth and weight gain of preterm infants with cord blood insulin and leptin was the aim of this study.
METHODOLOGY Study Population
A total of 215 preterm newborns born from July 2000 to May 2001 were admitted to the NICU of the Instituto Fernandes Figueira, in Rio de Janeiro. From these 215, congenital abnormalities and chromosomal disorders excluded 47 , with another 63 also eliminated for haemolysed blood samples (15) , coagulated blood (13), infants' illness (six), mothers' serious morbidity (two), nurse unavailability (13) broken test tube (five) and for small placenta (nine) as it was unable to collect blood sample to measure leptin and insulin levels. From the remaining 105 newborns, three died and six never returned for a follow-up visit.
Ethical approval for the study was obtained from Research Ethic Committee of the Instituto Fernandes Figueira, IFF ( Fundac¸ão Oswaldo Cruz, FIOCRUZ) and the mothers signed their informed consent.
Blood Assays and Data Collection
Cords were clamped at birth, blood samples were collected, centrifuged and stored at À801C freezer. Leptin levels were analysed using a Duoset Elisa Development kit (Research & Development System, Inc., Minneapolis, MN). The lower limit of detection was 0.1 ng/ml and the inter-assay and intraassay CV were 5.1 to 7.2 and 6.7 to 9.2%. Insulin levels were measured by a Radioimmunoassay (Linco Research, St Charles, Missouri, MO). The lower limit of insulin detection was 0.05 ng/ml and the interassay and intra-assay CV were 6.3 to 8.1 and 5.7 to 9.3%.
Anthropometric measurements were taken about 2 hours after delivery by the nursing staff. Weight was measured, every day, using electronic scales accurate to within 5 g. Length was obtained using a portable stadiometer accurate to 1 mm, every week, until discharge. Mother's stature was measured using a locally constructed stature board with a precision of 0.1 cm, and demographic and socioeconomic data were collected before discharge. Gestational age was determined by the mother's last menstrual period (87 newborns), early ultrasound dating (two newborns) or New Ballard Score examination (7 newborns). 13 Mothers participating in the study returned monthly until the children reached 6 months (corrected for gestational age) for growth and development follow-up, vaccines and counseling related to feeding practices. Breastfeeding is strongly recommended at the maternity with nursing and medical staffs trained to encourage the mothers' participation. During the follow-up visits, mothers gave details about feeding practices and morbidity in the previous month. Data on breastfeeding duration was categorized into approximate quintiles. Morbidity during follow-up period was numbered by days of infants' hospitalization as recommended by Desmond. 14 Only three children were hospitalized.
Statistical Analysis
Gender differences in the baseline anthropometric data and hormones were tested by Student's t-test. Variables between hormones at baseline and anthropometric changes, such as mother's stature, socioeconomic factors, newborn morbidity, breastfeeding practice and use of corticoid prepartum, were analysed for their associations to leptin and insulin at baseline through ANOVA, Student's t-test, or w 2 and logistic regression. Insulin and leptin were not normally distributed and were logtransformed for the univariate analysis and modeling.
For longitudinal data analysis, random regression models 15 were used to determine: (1) growth, measured by length; (2) weight gain, measured by the ponderal index (kg/m 3 ); and (3) fat mass change, measured by the body mass index BMI (kg/m 2 ) in relationship to leptin and insulin levels at birth.
The rate of change in length, weight gain and fatness were determined by temporal change rates of anthropometrics indexes using the PROC MIXED procedure, SAS, version 8.0 software. For each measure the hormone-by-time interaction variable estimated the change rate of outcomes.
Time was measured by the variable age incorporating the postnatal period as a continuous variable, centered at 40 weeks. Therefore the intercept outcome values corresponded to the expected term data. Models included a discontinuity in time (age) expressed by a variable called time40, that assumes value 1 for measures made after 40 weeks, and zero for measures made before 40 weeks, as suggested by Singer and Willett. 16 The discontinuity in time accounts for the greatest growth till 40 weeks. The residual plots for models of BMI, length, and ponderal index (PI) were transformed into square roots that linearized the relationship and stabilized the variance. For each one of the outcome models (BMI, length and PI) covariates included: duration of breastfeeding, birth weight, sex, birth gestational age, use of antenatal steroids (Yes/ No), mother's stature and mother's schooling, as shown in Table 1 . Only eight children developed late-onset sepsis and the variable for this morbidity was not included in the analysis. We assumed an exchangeable covariance structure of the models (compound symmetry), and models with random intercept and random slope were tested by the likelihood ratio test.
The final models were diagnosed for linear regression assumptions and influential cases.
RESULTS
Boys and girls showed no differences in the anthropometric measurements and cord blood hormone levels in this study. However, girls had a statistically significant lower mean gestational age (Table 1) in accordance with findings in the literature. Factors that could influence the growth and weight gain were studied for their association with cord leptin and insulin levels, where the only possible link noted was when mothers were treated with antenatal steroids (Table 2) . In fact, when we analysed the link between antenatal steroids in a multivariate regression model steroids were included in the model as a confounding variable. Preeclampsia accompanied by restricted fetal growth was present in 18 from 35 fetus that have been received antenatal steroids.
Cord blood leptin showed a strong and statistically significant positive association with birth weight, length, BMI and ponderal index at birth, but cord blood insulin did not correlate with anthropometric measures at birth, except for small and borderline cases for BMI (Table 3) .
The ponderal index, calculated from repeated random linear regression models, was neither related to insulin nor leptin .
Interactions for gender (sex * hormones * time variables) were not statistically significant (p>0.49), and random slope models were deleted.
Birth weight and gestational age were positively related to BMI and length changes (p<0.0001). Breastfeeding was a significant confounding variable only when the outcome was BMI (p ¼ 0.04), being negatively associated with BMI in the model with insulin. When the outcome was length, the mother's schooling was negatively associated (p ¼ 0.05) with length in the model with insulin. Antenatal Steroid use and mother's stature did not show statistically significant variations. The variable time40, which measures time before 40 gestational weeks, was positively associated with BMI and length, indicating a greater rate for this first followup period.
Leptin was negatively associated with the change rate of BMI (b ¼ À0.0031 p ¼ 0.01) and length (p<0.001), from birth until 64 postnatal weeks, as measured by the interaction term (age in weeks * hormone). The interaction variable estimated the change rate of outcomes, because the multiplicative term is only significant when the curves crossover. When the curves are parallel the change rates are similar. In Figure 1 , as children reached the same height at 64 weeks, those with low height and high leptin at birth had the greatest growth. Changes in BMI (Figure 1a ) and length (Figure 1b ) according to the lowest and highest quartiles of leptin are shown based on the predicted values of models II (Table 4 ). The analysis was undertaken with leptin as a continuous variable with the results being divided in quartiles in order to provide the estimated difference over the entire follow-up period, for the lowest and highest quartiles of the leptin values observed at baseline. Since the clinical significance of the small changes in leptin is so slight, the results are clarified when analysing the variable quartiles in Figure 1 , which shows that a difference of 1 cm at birth disappeared after 6 months of corrected gestational age.
DISCUSSION
Although circulating leptin and insulin concentration is linked to intrauterine growth and birth weight in full-term infants, there has been no inquiry into the influence of cord blood insulin and leptin for growth in preterm infants. Cord leptin is positively associated with birth weight, length and BMI as shown by studies with full-term infants, 5, 17 and preterms. 9 The greatest correlation of leptin is with BMI, indicating that even in preterm infants fatness is a leading factor. 18 Studies in term and preterm infants showed no relationship between anthropometric measures at birth and insulin, 19 which agrees with our findings.
There were no gender differences for leptin at birth in our study of term and preterm infants, 17, 20 thus contradicting respective studies of Ong et al. 7 and Ng et al., 9 although no links were found for cord insulin levels. 7 There was no link between gender and growth, nor change in PI and BMI during the 6 months follow-up, therefore both sexes being combined for all longitudinal analyses.
Catch-up growth in preterm infants is widely known; however, risk factors for catch-up are not fully understood. 21 Infections, 3 poor socio-economic conditions, 22 and feeding practices 23 are clearly related to growth. All of these factors relating hormones and growth were taken into account with our data clearly indicating that preterm infants show strong differences in the change rates for both BMI and length in the first weeks after birth, when compared to the rate after completing the 40 weeks (Figure 1) . Models showed the best fitness when allowing a discontinuity of time at 40 weeks.
Although children whose mothers received antenatal steroids had lower leptin levels, steroids did not have an independent association with BMI. Mean gestational age among mothers who received steroids was 32.6 vs 34.7, p<0.0001 when not used. Many of these fetus whose mothers received antenatal steroids in our study were born from pregnancies complicated by hypertension and were born by cesarean section and we need to revisit it in future studies to address intrauterine growth, since growth-restricted fetuses at term show umbilical cord leptin concentrations significantly lower than those in normal fetus, suggesting that fetal adipose tissue is a major source of leptin. Further studies are necessary to address this question, because we can have several hypotheses to explore. Despite this fact, there was a significant link between cord insulin concentration and body mass index at birth. During follow-up, there was no such association after adjustment for birth weight and gestational age. There is a paucity of data about preterm children insulin concentration, 24 there has been no link between the hormone action and concentration and the development in small-for-gestational-age children. 24 No link was found for BMI and weight with leptin for preterm infants; however, our results were similar to those of Ong et al. 7 whose results were for term infants. Children with lower leptin levels had greater change rates for both BMI and length since the hormone probably affects the hypothalamus. Leptin seems to act Figure 1 . Predicted values of body mass index.
on the ventromedial arcuate nucleus where it may interact with appetite-regulation system. Leptin decreases biosynthesis and secretion of the neuropeptide Y, which is an important appetite stimulator. 25, 26 In addition, leptin seems to interact in the brain with almost all neuropeptides known to be involved in the regulation of energy balance and, especially, food intake.
27 During infancy, the satiety level is an important determinant of weight gain. 12 So, leptin appears to play a major role in the control of body fat stores by coordinated regulation of feeding behaviour, metabolism, the autonomic nervous system and the body energy balance.
Leptin levels in the study population were very low when compared to term infants. In a longitudinal study of predominantly premature females during hospitalization, Speer et al. 28 found that leptin levels were very low in comparison to term babies, children and adults, which did not appreciably change in spite of caloric intake. It was speculated that a critical adipose storage level has to be attained before increased amounts of leptin are adequately produced. These persistently low leptin levels may also reflect an immaturity of the hypothalamic-pituitary-adrenal axis. Further follow-up of hormone quantification is needed to fully explain the hormonal changes associated with preterm growth and to determine how leptin levels correlate with catch-up growth in infants with small placentas. 
